American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 203-218 , August 2007

Angiogenesis Inhibitor Therapies: Focus on Kidney Toxicity and Hypertension

  • Hassane Izzedine, MD, PhD

      Affiliations

    • Department of Nephrology, Pitie-Salpetriere Hospital, Paris, France
    • Corresponding Author InformationAddress correspondence to Hassane Izzedine, MD, PhD, Department of Nephrology, La Pitié-Salpêtrière Hospital, 47-80 Boulevard de l’Hôpital, Assistance Publique-Hopitaux de Paris, Pierre et Marie Curie University, 75013 Paris, France.
    • ,
  • Olivier Rixe, MD, PhD

      Affiliations

    • Department of Medical Oncology, Pitie-Salpetriere Hospital, Paris, France.
    • ,
  • Bertrand Billemont, MD

      Affiliations

    • Department of Medical Oncology, Pitie-Salpetriere Hospital, Paris, France.
    • ,
  • Alain Baumelou, MD

      Affiliations

    • Department of Nephrology, Pitie-Salpetriere Hospital, Paris, France
    • ,
  • Gilbert Deray, MD

      Affiliations

    • Department of Nephrology, Pitie-Salpetriere Hospital, Paris, France

Received 19 December 2006 ,Accepted 24 April 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2007.04.025 on June 28, 2007.

PII: S0272-6386(07)00835-9

doi: 10.1053/j.ajkd.2007.04.025

American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 203-218 , August 2007

Article Tools

* Image Usage & Resolution